EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti‐CD19 Chimeric Antigen Receptor (CAR) T‐Cell Therapy

Anna Modoni iD, Catello Vollono, Eugenio Galli, Luca Capriati, Federica Sorà, Stefan Hohaus, Serenella Servidei, Nicola Piccirillo, Paolo Calabresi, Simona Sica

Brain and Behavior · 2025

DOI: 10.1002/brb3.70891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Anna Modoni und 9 weiteren Autor:innen. Beteiligte Einrichtung: UOC Neurologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Cytokine Release Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anti‐CD19 chimeric antigen receptor (CAR) T‐cell therapy is an innovative and effective treatment for patients with B‐cell hematological malignancies. Despite its high efficacy, it has been associated with the development of acute toxicities that can be severe or even fatal. Indeed, cytokine release syndrome (CRS) and immune effector cell‐associated neurotoxicity syndrome (ICANS) can induce significant morbidity and require close monitoring. Identification of clinical and laboratory markers able to predict the occurrence of ICANS may allow prompt recognition and more effective management strategies.

Methods

Here, we report a retrospective study on a cohort of 81 Italian adult patients treated in our hospital between September 2019 and April 2024. We reviewed all clinical, demographic, laboratory, and neurophysiological data in order to identify potential predictors.

Results

The results of the multivariate analysis confirmed that ICANS typically occurred less frequently in younger patients, especially when treated with 41BB co‐stimulated CAR‐T. Baseline EEG abnormalities are confirmed to be a fundamental predictor of neurotoxicity. Interestingly, we identified GammaGT as a new, statistically significant marker of ICANS. This represents a novel finding, probably related to the important role of GammaGT also in neuroinflammation.

Conclusions

Our results need to be confirmed in a larger cohort of patients in order to eventually be integrated into current clinical practice and management of patients undergoing CAR‐T.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurotoxicity SyndromesImmunotherapy, AdoptiveReceptors, Chimeric AntigenCytokine Release SyndromeHumansMaleFemaleMiddle AgedItalyRetrospective StudiesAdultAgedAntigens, CD19Cohort StudiesYoung AdultAged, 80 and overHematologic Neoplasms

Stichwörter der Autor:innen

CAR‐TEEGGammaGTICANSpredictors of neurotoxicity

Substanzen

Antigens, CD19Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • UOC Neurologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy.
  • UOC Neurofisiopatologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Dipartimento Di Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Sezione Di Ematologia, Dipartimento di Scienze Radiologiche Ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.

ORCID-Profile: Anna Modoni

Zitieren

APA

Modoni, A., Vollono, C., Galli, E., Capriati, L., Sorà, F., Hohaus, S., Servidei, S., Piccirillo, N., Calabresi, P., & Sica, S. (2025). Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti‐CD19 Chimeric Antigen Receptor (CAR) T‐Cell Therapy. Brain and Behavior. https://doi.org/10.1002/brb3.70891

Vancouver

Modoni A, Vollono C, Galli E, Capriati L, Sorà F, Hohaus S, et al. Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti‐CD19 Chimeric Antigen Receptor (CAR) T‐Cell Therapy. Brain and Behavior. 2025. doi:10.1002/brb3.70891

BibTeX
@article{Modoni2025,
  author = {Modoni, Anna and Vollono, Catello and Galli, Eugenio and Capriati, Luca and Sorà, Federica and Hohaus, Stefan and Servidei, Serenella and Piccirillo, Nicola and Calabresi, Paolo and Sica, Simona},
  title = {Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti‐CD19 Chimeric Antigen Receptor (CAR) T‐Cell Therapy},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70891}
}
Kostenlos starten →